Wepresent here a case of prominent hypercalcemia accompanied by hypothalamic tumor and Graves' disease. A24-year-old manwith hypothalamic tumor showed hypopituitarism, central diabetes inspidus (DI) and hyperthyroidism. Nausea, loss of thirst and appetite, and general fatigue were found with the unveiling of hypercalcemia and hypernatremia. Parathyroid hormone (PTH) and la-dihydroxyvitamin D levels were suppressed with a normal range of PTHrelated protein values. One-desamino-(8-D-arginine)-vasopressin (DDAVP)and half-saline administration normalized hypernatremia, while hypercalcemia was still sustained. Administration of cortisone acetate and thiamazole reduced the elevated serum Ca level. In the present case, concurrent hyperthyroidism was assumed to accelerate skeletal mobilization of calcium into the circulation. Hypocortisolism and central DI was also considered to contribute, to some extent, to the hypercalcemia through renal handling of Ca. (Internal Medicine 38: 486-490, 1999) 
Introduction
A neoplasm which develops in the hypothalamic region results in various degrees of adenohypophysial insufficiency as well as central diabetes inspidus (DI) due to compression and destruction of supraoptic and paraventricular nuclei where vasopressin is synthesized. The signs and symptomsof this disorder are highly variable: it is reported to accompany various endocrine abnormalities as well as disturbances of the autonomic nervous system (1) . In addition, disrupted serum sodium levels are often noted because of decreased vasopressin secretion and/or deranged adrenocorticotropic hormone (ACTH)-cortisol axis.
Although it is well recognized that primary hyperparathyroidism and malignancy constitute two main causes of hypercalcemia (2), thyrotoxicosis occasionally accompanies elevated serum Ca levels, occurring in approximately one-fifth of thyrotoxic patients (3) . An accelerated mobilization of Ca into circulation with increased turnover of bone is thought to cause hypercalcemia under normal parathyroid hormone (PTH) and la, 25-dihydroxyvitamin D3 [1 ,25(OH)2D3] feed-back (4) . Hypercalcemia associated with hyperthyroidism is, therefore, relatively mild: serum Ca levels are rarely greater than 12 mg/dl (5) . There are also somereports that, in glucocorticoid deficient states, hypercalcemia infrequently is manifest (6) . Although the precise mechanismremains unidentified, extracellular volumedepletion or dehydration is considered to contribute to the pathogenesis of hypercalcemia (7) . Furthermore, thyroid hormone administration before glucocorticoid replacement is knownto induce an unusually excessive reaction to the hormone. It is therefore possible that concurrent hyperthyroid Graves' disease would aggravate hypocortisolism. Here, we report a rare case of hypercalcemia accompanied by hypothalamic-associated disorders and coexisting hyperthyroidism.
Case Report
A 24-year-old man was admitted to Saitama Medical School Hospital on August ll, 1997, referred from a hospital in Los Angeles for evaluation and treatment of hypercalcemia and hypothalamic tumor. He had been well until six months before admission when he noticed increased thirst and polyuria. About one month before admission, he travelled to Los Angeles for his work. While there he complained of severe nausea and vomiting, and was found to have deranged serum electrolytes and a disturbed mental state. Radiological and laboratory examinations revealed hypothalamic tumor and elevated thyroid hormone levels. Administration of major tranquillizers, 1- of weight during the previous 6 months. His blood pressure was 128/88 mmHg. His urine excretion was mildly elevated to -4,500 ml. Orthostatic hypotension was not observed. Axillary and pubic hair was a typical male pattern and was not abnormal. No pigmentation was observed in his skin and mucosa. The thyroid gland was mostly normal in size and consistency. The patient was alert and no focal neurological signs were perceived. The sense of smell and thirst was not disturbed. Biochemical examination showed a mildly elevated uric acid level (8.6 mg/dl) and hypoalbuminemia (3.5 g/dl). Serum Ca and phosphate levels were kept within normal range with normal sodium and chloride levels. Hematological test showed a slight increase in white blood cells (9,470/mm3) with 5.0% of eosinophils. His hematocrit on admission was 32%. In basal endocrinological data, elevated free thyroxine (fT4) and free triiodothyronine (fT3) levels were noted with suppressed thyroid-stimulating hormone (TSH) levels (Table 1) . Autoantibodies to thyroglobulin and thyroid peroxidase were positive and sonography demonstrated a slightly enlarged thyroid gland with heterogenous echogenicity; increased vascularity was observed by color doppler method. Thyroidal uptake of 123I was 73%at 24 hours after 7MBqoral administration (normal range of our institute: less than 40%). These results showed that the patient's hyperthyroidism was due to Graves' disease. Sagittal section of head magnetic resonance imaging (MRI) revealed heterogeneously enhanced mass in the hypothalamus (Fig. 1) . The results of pituitary hormone tests are shown in Table 2 . Among anterior pituitary hormones, only growth hormone (GH) was responsive to GHreleasing hormone (GRH). Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) did not respond to LH-releasing hormone (LHRH). TSHwas low in its basal value and did not respond to thyrotropin-releasing hormone (TRH). Basal prolactin (PRL) value was elevated and its response was minimal against TRH. Although adrenal response could not be evaluated by rapid ACTHtest and repeated corticotropin-releasing hormone (CRH) test, the results of a single CRHtest as well as decreased basal ACTHand cortisol values were compatible for tertiary and/or secondary hypocortisolism. Water restriction test showed that urine osmolality did not exceed serum osmolality solely by 3.5 hours water restriction (urine osmolality: pre 74 mOsm/kgH2O; 3.5 hours 102 mOsm/ Examinations on Ca metabolism were investigated at the time of hypercalcemia. Serum Ca level was corrected with albumin according to Payne's report (20) .
kgH2O; serum osmolality: pre 301 mOsm/kgH2O;3.5 hours 306 mOsm/kgH2O; urine volume: pre 480 ml/0.5 hours; 3.5 hours 100 ml/0.5 hours), while exogenous DDAVP condensed urine osmolality higher than the serum (urine osmolality 350 mOsm/kgH2O;serum osmolality 310 mOsm/kgH2O;urine volume 25 ml/0.5 hours). The results indicate that polyuria observed in this case was primarily due to central DI.
During the hospitalization, nausea, loss of thirst and appetite, and general fatigue has been manifested. Polyuria due to central DI and loss of thirst aggravated hypernatremia. Following the increased stress states, serum Ca levels increased to -13 mg/dl with elevated serum phosphate level (5.0 mg/dl) (Fig. 2) . The results of examinations on Ca metabolism showed that PTHand la, 25-dihydroxyvitamin D levels were suppressed with a normal range of PTH-related protein values (intact PTH: <5 pg/ml; la, 25-dihydroxyvitamin D: <4 pg/ml; intact PTH-related protein: <1.1 pmol//). A bone metabolic marker, osteocalcin, was elevated to 3 1.6 ng/ml. Bone X-rays and 99mTcbone scinti scan did not show any evidence of bone lesions of malignancies. Since water restriction test showed central DI, hypernatremia and polyuria were treated with 2,000 ml of half-saline intravenous infusion and intranasal DDAVP administration. Although the urine volume was reduced with improvement of hypernatremia, hypercalcemia still persisted. Although usual replacement doses of cortisone acetate (25 mg) did not reduce the serum Ca levels, augmentation of cortisone acetate to 50 mg, along with thiamazole administration, gradually relieved hypercalcemia. Administration of two or more doses of cortisone acetate for hypocortisolism are recommended in the case of increased stress states. The case still showednausea and appetite loss at that time. Although craniotomy was first intended to remove the tumor, only removal of a small amount of the tumor was successful. Pathological test of the specimen showed mixed cell type of germinoma and teratoma. Following reduction of the tumor mass by irradiation, the tumor was resected again through craniotomy. The patient has been recovering fairly well.
Discussion
Serum concentration of Ca is normally kept within a nar- Anterior pituitary hormones and cortisol responses were assessed by administration of CRH (100 jig), TRH (500 |ig), LH-RH (100 jug) and GRH (100 jig). CRH: corticotropin-releasing hormone, GRH:growth hormone-releasing hormone, LH-RH:LH-releasing hormone, TRH:
thyrotropin-releasing hormone. row range by Ca homeostatic mechanismsinvolving an interplay of various hormonal and local factors (8) . Whenthis homeostatic control is impaired, serum Ca levels mayincrease or decrease beyond the normal range. Usually an impairment of Ca homeostasis occurs when production of Ca-regulatory hormonesis depleted or excessive, and becomes independent of control by serum Ca concentrations. Examplesof these are primary hyperparathyroidism and granulomatous disease; the latter is knownto accompany increased levels of 1 ,25(OH)2D (9) . There are also other well-known causes of hypercalcemia accompaniedby malignancies: humoral hypercalcemia of malignancy (HHM)and local osteolytic hypercalcemia (LOH). Although precise differentiation has been difficult between the two, recently developed PTH-related protein (PTHrP) assays allow us to generally differentiate these pathogeneses of hypercalcemia (10, ll) . In the present case, HHMand LOHis less probable due to a negative test of 99mTcbone scinti scan and normal range of intact PTHrPvalues, although a number of tumors have been demonstrated to produce various cytokines accelerating bone turnover (12) . The analyses of head MRI and computed tomographic scan did not show any destruction of the basal cranium, which is closest to the hypothalamic tumor. Moreover,the hypercalcemia observed in this case was improved solely by the half-saline infusion, hormonal replacement and thiamazole administration, prior to specific anti-tumor therapies. Concurrent hyperthyroidism and extracellular volume contraction might contribute to the hypercalcemia. The present case showed 32-37% of hematocrit before replacement of DDAVP and cortisone acetate, while it decreased to 25-26% after the therapy, indicating approximately 3-4 / of extracellular fluid deficit. Distal tubular sodium loss has been observed in glucocorticoid deficiency (13) , which would induce extracellular volume contraction, particularly when insufficient vasopressin secretion accelerated free water diuresis. Although initial hypercalcemia would, at least partly, be associated with this mechanism, sustained hypercalcemia could not be ameliorated solely by the correction of body fluid deficits (Fig. 2) . This indicates that other factors are also involved in the mechanism of hypercalcemia. There is also an intriguing report of hypercalcemic crisis in a hyperthyroid patient with central DI (14) . Although in that case, the authors speculated that hemoconcentration mainly contributed to the etiology of hypercalcemia, concurrent hyperthyroidism was also common for both cases. Hyperphosphatemia along with hypercalcemia suggests either increased bone resorption or vitamin D intoxication. The results of Ca-related examination in this case could deny the latter. We, therefore, speculated that hyperthyroidism induced the increase of bone resorption. The markedly elevated serum osteocalcin level was also compatible with the increased bone turnover. Thyroid hormone administration before glucocorticoid replacement is knownto induce an excessive reaction to the hormone in the case of adrenal failure. Concurrent hypocortisolism, therefore, seemed to precipitate cellular responses to thyroidal hormonesin peripheral tissues, for instance, in bone.
Although it has been pointed out that Addisonian patients infrequently accompany hypercalcemia, the majority of the reports is in older literature and its pathophysiology has not been elucidated (15) (16) (17) . Walser et al (17) studied the mechanism in early '60s. They found that hypercalcemia was severe in adrenalectomized dogs, but concentrations of free Ca ion were within the normal range, indicating that the elevated plasma protein concentration was involved in the mechanism. Since hypercalcemia was found in Ca-free diet dogs, they also speculated that hypercalcemia was not associated with the increased intestinal absorption of Ca.
Although TSHreceptor antibody was within the normal range, positive tests for autoantibodies to thyroperoxidase and thyroglobulin suggested that the hyperthyroidism is associated with autoimmune thyroid disease. Furthermore, the increased vascularity of the thyroid and 123I uptake indicated that silent and subacute thyroiditis was negligible, and the diagnosis was most probable for Graves' disease. tion tests (Table 1) suggested that the pituitary function was influenced by the hypothalamic tumor and hyperthyroidism. Although the elevated basal PRLvalue was compatible with disruption of hypothalamic inhibitory regulation to PRLsecretion, due to hypothalamic tumor, the lack of response of PRL and TSHto TRHwould also indicate that the excessive thyroidal hormonescontinuously suppressed the responsiveness to TRHand/or tumor involvement to pituitary tissue. This would also be the case for the results of the LH-RHtest. As we have shown previously, glucocorticoid affects the TSH-thyroid axis, which is more easily seen in patients with intrinsic thyroid disease (18) . Physiological concentrations of glucocorticoid mayhave a suppressive effect on the manifestation of autoimmune thyroid disease. It is, therefore, of interest that the hyperthyroidism due to Graves' disease was accompanied by hypocortisolism in this case. Autoimmune thyroiditis is fairly commonin Japanese, and about 10-20% of the female population and about 5%of the male are positive for the anti-microsomal and anti-thyroglobulin antibody (19) . Solely 3% of the patients with ACTHdeficiency represent hyperthyroidism, as we have shownpreviously (18) . These results may not support the concept that the prevalence of autoimmunethyroid disease is significantly higher in patients with secondary and tertiary hypocortisolism than in the Japanese general population.
In summary,here we presented a rare case of hypercalcemia accompanied by hypocortisolism, central DI and hyperthyroidism. All these disorders seemed to be involved in the pathogenesis of hypercalcemia.
